Pfizer appoints obesity discovery head; AI startup Xaira makes leadership adjustments
Danna Breen has succeeded Kendra Bence as head of obesity discovery at Pfizer after nearly 14 years with the company as a scientist and research fellow.
Read the full articleYou might also wanna read
Weight-loss drug developers line up to tap lucrative market as competition heats up
HEALTH-OBESITY:Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up
Aureka Opens Its Drug Discovery Model as AI Biotech Moves Toward Lab-Linked Systems
Founder and CEO Dr. Weian Zhao is putting OpenDDE in public view while Aureka keeps its wet-lab data flywheel proprietary.
Research on the Needs, Feasibility, and Intervention Effects of AI Health Coach-based Just-in-Time Adaptive Intervention (JITAI) in Weight Management for Overweight/Obese Adults
Conditions : Overweight , Obesity Interventions : Behavioral: AI Health Coach-based Just-in-Time Adaptive Intervention Sponsors : The Fourth
‘CROWN JEWEL’: Pfizer CEO touts ‘TREMENDOUS SUCCESSES’ in oncology R&D
Pfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI’
BHVN Stock Builds Momentum Ahead Of Multiple H2 2026 Clinical Data Readouts
The company is expected to announce clinical data for hard-to-treat epilepsy and obesity later this year.
Kailera's big obesity reveal puts pressure on shares
Kailera's big obesity reveal puts pressure on shares Phil.Taylor Wed, 08/07/2026 - 08:55
Comments
Sign in to join the conversation.
No comments yet. Be the first.